Profund Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Sell
36,834
-6,344
-15% -$370K 0.08% 192
2025
Q4
$2.57M Buy
43,178
+8,443
+24% +$460K 0.08% 155
2025
Q3
$1.88M Sell
34,735
-2,651
-7% -$152K 0.06% 203
2025
Q2
$2.06M Buy
37,386
+7,341
+24% +$432K 0.07% 179
2025
Q1
$2.12M Sell
30,045
-11,661
-28% -$785K 0.09% 166
2024
Q4
$2.74M Sell
41,706
-1,216
-3% -$81.5K 0.1% 139
2024
Q3
$3.02M Sell
42,922
-1,741
-4% -$146K 0.11% 138
2024
Q2
$3.68M Buy
44,663
+28,505
+176% +$2.37M 0.14% 111
2024
Q1
$1.41M Buy
16,158
+914
+6% +$81.8K 0.06% 251
2023
Q4
$1.47M Sell
15,244
-963
-6% -$85.2K 0.06% 251
2023
Q3
$1.43M Buy
16,207
+65
+0.4% +$5.78K 0.08% 198
2023
Q2
$1.4M Buy
16,142
+2,478
+18% +$233K 0.08% 230
2023
Q1
$1.33M Sell
13,664
-7,066
-34% -$733K 0.08% 221
2022
Q4
$2.15M Buy
20,730
+505
+2% +$47.4K 0.14% 138
2022
Q3
$1.71M Sell
20,225
-914
-4% -$81.4K 0.12% 151
2022
Q2
$1.75M Sell
21,139
-1,732
-8% -$138K 0.11% 163
2022
Q1
$1.76M Sell
22,871
-2,375
-9% -$199K 0.07% 214
2021
Q4
$2.23M Sell
25,246
-4,487
-15% -$370K 0.07% 193
2021
Q3
$2.3M Sell
29,733
-1,455
-5% -$115K 0.08% 202
2021
Q2
$2.6M Sell
31,188
-843
-3% -$66.8K 0.09% 188
2021
Q1
$2.42M Sell
32,031
-4,955
-13% -$405K 0.09% 177
2020
Q4
$3.24M Sell
36,986
-7,213
-16% -$572K 0.14% 128
2020
Q3
$3.36M Sell
44,199
-5,830
-12% -$590K 0.17% 103
2020
Q2
$6.17M Buy
50,029
+6,668
+15% +$663K 0.34% 50
2020
Q1
$3.66M Sell
43,361
-14,505
-25% -$1.25M 0.28% 67
2019
Q4
$4.89M Buy
57,866
+6,023
+12% +$455K 0.21% 88
2019
Q3
$3.49M Sell
51,843
-2,639
-5% -$203K 0.18% 102
2019
Q2
$4.67M Sell
54,482
-4,559
-8% -$390K 0.22% 83
2019
Q1
$5.25M Buy
59,041
+747
+1% +$69.2K 0.25% 66
2018
Q4
$4.96M Sell
58,294
-13,515
-19% -$1.29M 0.31% 56
2018
Q3
$6.96M Buy
71,809
+6,457
+10% +$645K 0.26% 60
2018
Q2
$6.16M Sell
65,352
-2,678
-4% -$235K 0.25% 61
2018
Q1
$5.51M Sell
68,030
-5,543
-8% -$476K 0.22% 71
2017
Q4
$6.56M Sell
73,573
-8,176
-10% -$711K 0.25% 62
2017
Q3
$7.61M Buy
81,749
+5,989
+8% +$529K 0.32% 47
2017
Q2
$6.88M Sell
75,760
-3,343
-4% -$304K 0.31% 52
2017
Q1
$6.94M Sell
79,103
-5,468
-6% -$486K 0.31% 47
2016
Q4
$7.01M Sell
84,571
-11,630
-12% -$1M 0.32% 42
2016
Q3
$8.9M Buy
96,201
+949
+1% +$89.4K 0.42% 32
2016
Q2
$7.41M Sell
95,252
-3,618
-4% -$308K 0.36% 32
2016
Q1
$8.15M Sell
98,870
-23,041
-19% -$1.87M 0.42% 27
2015
Q4
$12.8M Buy
121,911
+37
+0% +$3.86K 0.61% 24
2015
Q3
$12.8M Buy
121,874
+2,145
+2% +$287K 0.73% 20
2015
Q2
$16.4M Buy
119,729
+2,440
+2% +$302K 0.68% 20
2015
Q1
$14.6M Buy
117,289
+12,349
+12% +$1.31M 0.57% 20
2014
Q4
$9.49M Buy
104,940
+12,874
+14% +$1.07M 0.39% 30
2014
Q3
$6.64M Buy
92,066
+6,656
+8% +$437K 0.31% 43
2014
Q2
$5.31M Sell
85,410
-20,853
-20% -$1.26M 0.23% 57
2014
Q1
$7.25M Buy
106,263
+20,482
+24% +$1.51M 0.33% 36
2013
Q4
$6.03M Buy
85,781
+19,100
+29% +$1.3M 0.27% 41
2013
Q3
$4.82M Buy
66,681
+3,176
+5% +$211K 0.26% 48
2013
Q2
$3.54M Buy
+63,505
New +$3.96M 0.25% 61

Other funds holding BMRN